Drug Shortage Report for MYLAN-AMLODIPINE
Report ID | 28029 |
Drug Identification Number | 02272121 |
Brand name | MYLAN-AMLODIPINE |
Common or Proper name | AMLODIPINE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | AMLODIPINE |
Strength(s) | 10.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100BT, 500BT |
ATC code | C08CA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-01-31 |
Actual start date | 2018-01-31 |
Estimated end date | 2018-02-09 |
Actual end date | 2018-02-09 |
Shortage status | Resolved |
Updated date | 2018-02-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.